Study of the RESS Process for Micronization of Clofibric acid and Thymol

碩士 === 國立臺灣大學 === 化學工程學研究所 === 104 === In this study, RESS process was applied for micronization and recrystallization of two active pharmaceutical ingredients (APIs) including clofibric acid and thymol. Also, Taguchi Method has been used to design for the experiment. Taguchi’s parameter design...

Full description

Bibliographic Details
Main Authors: Hao-Chih Chien, 簡豪志
Other Authors: Yan-Ping Chen
Format: Others
Language:zh-TW
Published: 2016
Online Access:http://ndltd.ncl.edu.tw/handle/77726420477263782323
id ndltd-TW-104NTU05063023
record_format oai_dc
spelling ndltd-TW-104NTU050630232017-04-24T04:23:46Z http://ndltd.ncl.edu.tw/handle/77726420477263782323 Study of the RESS Process for Micronization of Clofibric acid and Thymol 利用超臨界溶液快速膨脹法進行藥物氯貝酸與百里酚之微粒化研究 Hao-Chih Chien 簡豪志 碩士 國立臺灣大學 化學工程學研究所 104 In this study, RESS process was applied for micronization and recrystallization of two active pharmaceutical ingredients (APIs) including clofibric acid and thymol. Also, Taguchi Method has been used to design for the experiment. Taguchi’s parameter design is an important tool for robust design. It offers a simple and systematic approach to optimize design for performance, quality and cost. After RESS processed, the submicron particles were precipitated in the expansion vessel with various effects of operating factors like extraction temperature (Text), extraction pressure (Pext), post temperature (Tpost), and the nozzle diameter (DN). Then, the original and micronized APIs were evaluated by SEM, FTIR, DSC, XRD and TGA analysis. Moreover, the comparison of the dissolution profile between original and RESS-processed APIs was also shown in this study. For clofibric acid, the particle size was dramatically reduced from 97.41 μm to 1.01 μm by RESS process. There was no change of the physical and chemical properties after the RESS process. Also, the decrease of crystallinity can be observed in the XRD result. Results from Taguchi method and analysis of variance (ANOVA) showed that nozzle diameter was the most significant factor. Then, the dissolution rate constant (kw) of original and RESS-processed particles can be calculated by optimally fitting the data points with Weibull model. As a result, the rate of dissolution only enhanced 1.85 times. Similar result can be discovered in the API thymol through RESS process. The mean particle size was significantly micronized from 1385.21 μm to 21.35 μm. Although no polymorphic transformation was found, the crystallinity of RESS-processed thymol diminished. Besides, the physical and chemical properties of the thymol remained the same. Results from Taguchi method and analysis of variance (ANOVA) showed that post-expansion temperature was the most important factor. Dissolution studies reported that the dissolution rate improved 4.42 times. Yan-Ping Chen 陳延平 2016 學位論文 ; thesis 100 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立臺灣大學 === 化學工程學研究所 === 104 === In this study, RESS process was applied for micronization and recrystallization of two active pharmaceutical ingredients (APIs) including clofibric acid and thymol. Also, Taguchi Method has been used to design for the experiment. Taguchi’s parameter design is an important tool for robust design. It offers a simple and systematic approach to optimize design for performance, quality and cost. After RESS processed, the submicron particles were precipitated in the expansion vessel with various effects of operating factors like extraction temperature (Text), extraction pressure (Pext), post temperature (Tpost), and the nozzle diameter (DN). Then, the original and micronized APIs were evaluated by SEM, FTIR, DSC, XRD and TGA analysis. Moreover, the comparison of the dissolution profile between original and RESS-processed APIs was also shown in this study. For clofibric acid, the particle size was dramatically reduced from 97.41 μm to 1.01 μm by RESS process. There was no change of the physical and chemical properties after the RESS process. Also, the decrease of crystallinity can be observed in the XRD result. Results from Taguchi method and analysis of variance (ANOVA) showed that nozzle diameter was the most significant factor. Then, the dissolution rate constant (kw) of original and RESS-processed particles can be calculated by optimally fitting the data points with Weibull model. As a result, the rate of dissolution only enhanced 1.85 times. Similar result can be discovered in the API thymol through RESS process. The mean particle size was significantly micronized from 1385.21 μm to 21.35 μm. Although no polymorphic transformation was found, the crystallinity of RESS-processed thymol diminished. Besides, the physical and chemical properties of the thymol remained the same. Results from Taguchi method and analysis of variance (ANOVA) showed that post-expansion temperature was the most important factor. Dissolution studies reported that the dissolution rate improved 4.42 times.
author2 Yan-Ping Chen
author_facet Yan-Ping Chen
Hao-Chih Chien
簡豪志
author Hao-Chih Chien
簡豪志
spellingShingle Hao-Chih Chien
簡豪志
Study of the RESS Process for Micronization of Clofibric acid and Thymol
author_sort Hao-Chih Chien
title Study of the RESS Process for Micronization of Clofibric acid and Thymol
title_short Study of the RESS Process for Micronization of Clofibric acid and Thymol
title_full Study of the RESS Process for Micronization of Clofibric acid and Thymol
title_fullStr Study of the RESS Process for Micronization of Clofibric acid and Thymol
title_full_unstemmed Study of the RESS Process for Micronization of Clofibric acid and Thymol
title_sort study of the ress process for micronization of clofibric acid and thymol
publishDate 2016
url http://ndltd.ncl.edu.tw/handle/77726420477263782323
work_keys_str_mv AT haochihchien studyoftheressprocessformicronizationofclofibricacidandthymol
AT jiǎnháozhì studyoftheressprocessformicronizationofclofibricacidandthymol
AT haochihchien lìyòngchāolínjièróngyèkuàisùpéngzhàngfǎjìnxíngyàowùlǜbèisuānyǔbǎilǐfēnzhīwēilìhuàyánjiū
AT jiǎnháozhì lìyòngchāolínjièróngyèkuàisùpéngzhàngfǎjìnxíngyàowùlǜbèisuānyǔbǎilǐfēnzhīwēilìhuàyánjiū
_version_ 1718444119250960384